← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. MASI
  3. P/E History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

MASI logoMasimo Corporation (MASI) P/E Ratio History

Historical price-to-earnings valuation from 2007 to 2026

Current P/E
-63.7
Undervalued
5Y Avg P/E
68.6
-193% vs avg
PE Percentile
0%
Low
PEG Ratio
N/A
N/A
TTM EPS$1.45
Price$178.49
5Y PE Range39.2 - 122.3
Earnings YieldN/A

Loading P/E history...

MASI Valuation Context

How does the current P/E compare to historical and market benchmarks?

vs. 5Y Average
-63.7vs68.6
-193%
Cheap vs History
vs. Healthcare
-63.7vs22.1
-388%
Below Sector
vs. S&P 500
-63.7vs25.2
-353%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on 51% EPS growth (1Y)
Export Data

P/E Ratio Analysis

As of May 6, 2026, Masimo Corporation (MASI) trades at a price-to-earnings ratio of -63.7x, with a stock price of $178.49 and trailing twelve-month earnings per share of $1.45.

The current P/E is 193% below its 5-year average of 68.6x. Over the past five years, MASI's P/E has ranged from a low of 39.2x to a high of 122.3x, placing the current valuation at the 0th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.1x, MASI trades at a 388% discount to its sector peers. The sector includes 242 companies with P/E ratios ranging from 0.0x to 178.0x.

Relative to the broader market, MASI trades at a notable discount to the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our MASI DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

MASI P/E vs Peers

P/E ratio compared to closely matched public peers

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
PODD logoPODDInsulet Corporation
$11B43.40.42-40%
HOLX logoHOLXHologic, Inc.
$17B30.5--25%
ITGR logoITGRInteger Holdings Corporation
$3B29.96.78-15%
ICUI logoICUIICU Medical, Inc.
$3B3986.3-+101%
INVA logoINVAInnoviva, Inc.
$2B6.8Lowest0.66+817%Best
NOVT logoNOVTNovanta Inc.
$5B94.528.67-17%
MMSI logoMMSIMerit Medical Systems, Inc.
$4B28.9-+5%
HAYW logoHAYWHayward Holdings, Inc.
$3B21.90.16Best+26%

Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.

MASI Historical P/E Data (2007–2026)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterDatePriceTTM EPSP/E Ratiovs Avg
FY2026 Q1Sat Apr 04 2026 00:00:00 GM$178.59$1.46122.3x+209%
FY2024 Q3Sat Sep 28 2024 00:00:00 GM$133.20$1.4591.9x+132%
FY2024 Q2Sat Jun 29 2024 00:00:00 GM$125.94$1.4785.7x+116%
FY2024 Q1Sat Mar 30 2024 00:00:00 GM$146.85$1.4799.9x+152%
FY2023 Q4Sun Dec 31 2023 00:00:00 GM$117.21$1.5177.6x+96%
FY2023 Q3Sat Sep 30 2023 00:00:00 GM$87.68$1.6353.8x+36%
FY2023 Q2Sat Jul 01 2023 00:00:00 GM$164.55$2.1377.3x+95%
FY2023 Q1Sat Apr 01 2023 00:00:00 GM$184.54$2.1785.0x+115%
FY2022 Q4Sat Dec 31 2022 00:00:00 GM$147.95$2.5957.1x+44%
FY2022 Q3Sat Oct 01 2022 00:00:00 GM$141.16$3.0246.7x+18%
FY2022 Q2Sat Jul 02 2022 00:00:00 GM$135.90$3.3240.9x+3%
FY2022 Q1Sat Apr 02 2022 00:00:00 GM$151.71$3.8739.2x-1%

Average P/E for displayed period: 39.6x

See MASI's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is MASI Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare MASI vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

MASI — Frequently Asked Questions

Quick answers to the most common questions about buying MASI stock.

Is MASI stock overvalued or undervalued?

MASI trades at -63.7x P/E, below its 5-year average of 68.6x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.

How does MASI's valuation compare to peers?

Masimo Corporation P/E of -63.7x compares to sector median of 22.1x. The discount suggests lower growth expectations or higher risk.

What is MASI's PEG ratio?

MASI PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2007-2026.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

MASI P/E Ratio History (2007–2026)

P/E ratio calculated as closing price divided by trailing 12-month diluted EPS at each quarter end.